Tackling the stigma associated with human immunodeficiency virus (HIV) and promoting effective communication between healthcare professionals and people with HIV (PWH) were the focus of a special workshop held in Bahrain.
The programme was sponsored by Gilead Sciences in collaboration with the Health Ministry and leading healthcare experts.
The California-based biopharmaceutical company is most known for researching and developing antiviral drugs used to treat HIV/Aids, hepatitis B, hepatitis C, influenza and Covid-19.
